Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04DXA
|
|||
| Former ID |
DNCL003542
|
|||
| Drug Name |
Tofogliflozin
|
|||
| Synonyms |
TOFOGLIFLOZIN; 903565-83-3; CSG 452; Tofogliflozin anhydrous; UNII-554245W62T; CSG-452; 554245W62T; deberza; apleway; Tofogliflozin [INN]; R-7201; Tofogliflozin anyhydrous; Tube107; EC 619-989-0; SCHEMBL903156; GTPL9395; CHEMBL2110731; DTXSID90238097; CSG452;CSG-452; CHEBI:136041; MolPort-044-723-920; ZINC35826342; BDBM50396779; AKOS027250822; DB11824; SB11170; compound 16d [PMID: 22889351]; NCGC00485920-01; KB-76204
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Type-2 diabetes [ICD-11: 5A11] | Approved | [1] | |
| Company |
Genentech
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H26O6
|
|||
| Canonical SMILES |
CCC1=CC=C(C=C1)CC2=CC3=C(COC34C(C(C(C(O4)CO)O)O)O)C=C2
|
|||
| InChI |
1S/C22H26O6/c1-2-13-3-5-14(6-4-13)9-15-7-8-16-12-27-22(17(16)10-15)21(26)20(25)19(24)18(11-23)28-22/h3-8,10,18-21,23-26H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22+/m1/s1
|
|||
| InChIKey |
VWVKUNOPTJGDOB-BDHVOXNPSA-N
|
|||
| CAS Number |
CAS 903565-83-3
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| ChEBI ID |
CHEBI:136041
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Tofogliflozin: first global approval. Drugs. 2014 Jun;74(8):939-44. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.